Sophiris Bio Inc. announced the appointment of Gerald T. Proehl to its board of directors effective March 19, 2014. Mr. Proehl most recently served as the president, chief executive officer and director of Santarus, Inc. until its acquisition by Salix Pharmaceuticals, Inc. in January 2014. Mr. Proehl was also appointed as a member of both the audit committee and the corporate governance and nomination committee.

Mr. Proehl will serve until the company's 2014 annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal.